Watch this webinar on the J&J website: you’ll glean insights for stakeholder perspectives on how early-stage companies have been able to leverage small non-dilutive funding to advance their platform technologies and generate additional funding from investors and organizations, including the U.S. National Institutes of Health, U.S. Department of Defense, the Bill and Melinda Gates Foundations, and the Coalition for Epidemic Preparedness (CEPI). Beyond direct monetary support, non-dilutive funding proves invaluable for propelling them toward scientific milestones and generating data that can be a driver in attracting investors.